250 related articles for article (PubMed ID: 31050611)
1. Defining a Liver Transplant Benefit Threshold for the Model for End-Stage Liver Disease-Sodium Score.
Beal EW; Akateh C; Tumin D; Bagante F; Black SM; Washburn K; Azouley D; Pawlik TM
Exp Clin Transplant; 2020 Aug; 18(4):491-497. PubMed ID: 31050611
[TBL] [Abstract][Full Text] [Related]
2. Serum sodium and survival benefit of liver transplantation.
Sharma P; Schaubel DE; Goodrich NP; Merion RM
Liver Transpl; 2015 Mar; 21(3):308-13. PubMed ID: 25504743
[TBL] [Abstract][Full Text] [Related]
3. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.
Kim WR; Mannalithara A; Heimbach JK; Kamath PS; Asrani SK; Biggins SW; Wood NL; Gentry SE; Kwong AJ
Gastroenterology; 2021 Dec; 161(6):1887-1895.e4. PubMed ID: 34481845
[TBL] [Abstract][Full Text] [Related]
4. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW
Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
[TBL] [Abstract][Full Text] [Related]
5. A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation.
Leise MD; Kim WR; Kremers WK; Larson JJ; Benson JT; Therneau TM
Gastroenterology; 2011 Jun; 140(7):1952-60. PubMed ID: 21334338
[TBL] [Abstract][Full Text] [Related]
6. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
Kwong AJ; Lai JC; Dodge JL; Roberts JP
Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
[TBL] [Abstract][Full Text] [Related]
7. Model for end-stage liver disease and model for end-stage liver disease-Na scores predict both before-listing and wait-list mortality.
Yamashiki N; Sugawara Y; Tamura S; Kaneko J; Nojiri K; Aoki T; Sakamoto Y; Hasegawa K; Koike K; Kokudo N
Transplant Proc; 2012 Mar; 44(2):389-92. PubMed ID: 22410024
[TBL] [Abstract][Full Text] [Related]
8. MELD-XI Score and Coronary Artery Disease Prevalence and Extent Among In-Hospital Patients With End-Stage Liver Failure Awaiting Transplant.
Keskin S; Çiftci O; Moray G; Müderrisoğlu H; Haberal M
Exp Clin Transplant; 2020 Jan; 18(Suppl 1):88-92. PubMed ID: 32008505
[TBL] [Abstract][Full Text] [Related]
9. End-stage liver disease candidates at the highest model for end-stage liver disease scores have higher wait-list mortality than status-1A candidates.
Sharma P; Schaubel DE; Gong Q; Guidinger M; Merion RM
Hepatology; 2012 Jan; 55(1):192-8. PubMed ID: 21898487
[TBL] [Abstract][Full Text] [Related]
10. Factors that affect deceased donor liver transplantation rates in the United States in addition to the Model for End-stage Liver Disease score.
Sharma P; Schaubel DE; Messersmith EE; Guidinger MK; Merion RM
Liver Transpl; 2012 Dec; 18(12):1456-63. PubMed ID: 22965903
[TBL] [Abstract][Full Text] [Related]
11. Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list.
Myers RP; Shaheen AA; Faris P; Aspinall AI; Burak KW
PLoS One; 2013; 8(1):e51926. PubMed ID: 23349678
[TBL] [Abstract][Full Text] [Related]
12. Survival Benefit of Living-Donor Liver Transplant.
Jackson WE; Malamon JS; Kaplan B; Saben JL; Schold JD; Pomposelli JJ; Pomfret EA
JAMA Surg; 2022 Oct; 157(10):926-932. PubMed ID: 35921119
[TBL] [Abstract][Full Text] [Related]
13. Model for end-stage liver disease-sodium and survival benefit in liver transplantation.
Vitale A; Bertacco A; Gambato M; D'Amico F; Morales RR; Frigo AC; Zanus G; Burra P; Angeli P; Cillo U
Transpl Int; 2013 Feb; 26(2):138-44. PubMed ID: 23194386
[TBL] [Abstract][Full Text] [Related]
14. The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation.
Györi GP; Pereyra D; Rumpf B; Hackl H; Köditz C; Ortmayr G; Reiberger T; Trauner M; Berlakovich GA; Starlinger P
Hepatology; 2020 Aug; 72(2):584-594. PubMed ID: 31773739
[TBL] [Abstract][Full Text] [Related]
15. Sex Disparity in Liver Transplant and Access to Living Donation.
Karnam RS; Chen S; Xu W; Chen C; Elangainesan P; Ghanekar A; McGilvray I; Reichman T; Sayed B; Selzner M; Sapisochin G; Galvin Z; Hirschfield G; Asrani SK; Selzner N; Cattral M; Lilly L; Bhat M
JAMA Surg; 2021 Nov; 156(11):1010-1017. PubMed ID: 34406347
[TBL] [Abstract][Full Text] [Related]
16. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
[TBL] [Abstract][Full Text] [Related]
17. Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes.
Nagai S; Chau LC; Schilke RE; Safwan M; Rizzari M; Collins K; Yoshida A; Abouljoud MS; Moonka D
Gastroenterology; 2018 Nov; 155(5):1451-1462.e3. PubMed ID: 30056096
[TBL] [Abstract][Full Text] [Related]
18. Model for End-Stage Liver Disease and Seven Derivations to Prioritize Liver Transplant Candidates: Which Is the Winner?
Tohidinezhad F; Eslami S; Abu-Hanna A; Aliakbarian M
Exp Clin Transplant; 2018 Dec; 16(6):721-729. PubMed ID: 29457445
[TBL] [Abstract][Full Text] [Related]
19. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC;
Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694
[TBL] [Abstract][Full Text] [Related]
20. Validation of the five-variable Model for End-stage Liver Disease (5vMELD) for prediction of mortality on the liver transplant waiting list.
Myers RP; Tandon P; Ney M; Meeberg G; Faris P; Shaheen AA; Aspinall AI; Burak KW
Liver Int; 2014 Sep; 34(8):1176-83. PubMed ID: 24256642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
